Works matching IS 08876924 AND DT 2007 AND VI 21 AND IP 8

Results: 40

The rho-kinase inhibitors Y-27632 and fasudil act synergistically with imatinib to inhibit the expansion of ex vivo CD34(+) CML progenitor cells.

Published in:

2007

By:

Burthem, J;
Rees-Unwin, K;
Mottram, R;
Adams, J;
Lucas, G S;
Spooncer, E;
Whetton, A D

Publication type:

journal article

JAK2V617F as progression marker in CMPD and as cooperative mutation in AML with trisomy 8 and t(8;21): a comparative study on 1103 CMPD and 269 AML cases.

Published in:

2007

By:

Schnittger, S.;
Bacher, U.;
Kern, W.;
Haferlach, T.;
Haferlach, C.

Publication type:

Letter

Reply to Rituximab activity in CD20 positive multiple myeloma.

Published in:

2007

By:

Gozzetti, A.;
Fabbri, A.;
Lazzi, S.;
Bocchia, M.;
Lauria, F.

Publication type:

Letter

Efficacy and safety of low-dose alemtuzumab as treatment of autoimmune hemolytic anemia in pretreated B-cell chronic lymphocytic leukemia.

Published in:

2007

By:

Laurenti, L.;
Tarnani, M.;
Efremov, D. G.;
Chiusolo, P.;
De Padua, L.;
Sica, S.;
Leone, G.

Publication type:

Letter

Reply to ‘Efficacy and safety of low-dose alemtuzumab as treatment of autoimmune hemolytic anemia in pretreated B-cell chronic lymphocytic leukemia’ by Dr Laurenti et al.

Published in:

2007

By:

Lundin, J.

Publication type:

Letter

Analysis of BCL-6, CD95, PIM1, RHO/TTF and PAX5 mutations in splenic and nodal marginal zone B-cell lymphomas suggests a particular B-cell origin.

Published in:

2007

By:

Traverse-Glehen, A.;
Verney, A.;
Baseggio, L.;
Felman, P.;
Callet-Bauchu, E.;
Thieblemont, C.;
Ffrench, M.;
Magaud, J.-P.;
Coiffier, B.;
Berger, F.;
Salles, G.

Publication type:

Letter

Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens.

Published in:

Leukemia (08876924), 2007, v. 21, n. 8, p. 1628, doi. 10.1038/sj.leu.2404681

By:

Jiménez, M.;
Ercilla, G.;
Martínez, C.

Publication type:

Article

Monosomy 7 in myeloid malignancies: parental origin and monitoring by real-time quantitative PCR.

Published in:

2007

By:

Porta, G.;
Maserati, E.;
Mattarucchi, E.;
Minelli, A.;
Pressato, B.;
Valli, R.;
Zecca, M.;
Bernardo, M. E.;
Curto, F. Lo;
Locatelli, F.;
Danesino, C.;
Pasquali, F.

Publication type:

Letter

JAK2V617F prevalence and allele burden in non-splanchnic venous thrombosis in the absence of overt myeloproliferative disorder.

Published in:

2007

By:

Pardanani, A.;
Lasho, T. L.;
Schwager, S.;
Finke, C.;
Hussein, K.;
Pruthi, R. K.;
Tefferi, A.

Publication type:

Letter

Lenalidomide therapy in del(5)(q31)-associated myelofibrosis: cytogenetic and JAK2V617F molecular remissions.

Published in:

2007

By:

Tefferi, A.;
Lasho, T. L.;
Mesa, R. A.;
Pardanani, A.;
Ketterling, R. P.;
Hanson, C. A.

Publication type:

Letter

Treatment of severe autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab.

Published in:

2007

By:

Royer, B.;
Vaida, I.;
Etienne, A.;
Garidi, R.;
Damaj, G.;
Marolleau, J. P.

Publication type:

Case Study

Prognostic analysis of aberrant somatic hypermutation of RhoH gene in diffuse large B cell lymphoma.

Published in:

2007

By:

Hiraga, J.;
Katsumi, A.;
Iwasaki, T.;
Abe, A.;
Kiyoi, H.;
Matsushita, T.;
Kinoshita, T.;
Naoe, T.

Publication type:

Letter

The HOXB4 homeoprotein improves ex vivo generation of functional human NK-cell progenitors.

Published in:

2007

By:

Haddad, R.;
Caignard, A.;
Visentin, G.;
Vigon, I.;
Fichelson, S.;
Amsellem, S.

Publication type:

Letter

A novel ETV6-PDGFRB fusion transcript missed by standard screening in a patient with an imatinib responsive chronic myeloproliferative disease.

Published in:

2007

By:

Curtis, C. E.;
Grand, F. H.;
Waghorn, K.;
Sahoo, T. P.;
George, J.;
Cross, N. C. P.

Publication type:

Letter

Concurrent JAK2(V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis.

Published in:

2007

By:

Bornhäuser, M.;
Mohr, B.;
Oelschlaegel, U.;
Bornhäuser, P.;
Jacki, S.;
Ehninger, G.;
Thiede, C.

Publication type:

Letter

Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: a randomized multicenter trial by the EBMT Chronic Leukemia Working Party

Published in:

2007

By:

Knop, S.;
Hebart, H.;
Gratwohl, A.;
Kliem, C.;
Faul, C.;
Holler, E.;
Apperley, J.;
Kolb, H. J.;
Schaefer, A.;
Niederwieser, D.;
Einsele, H.

Publication type:

Letter

The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.

Published in:

Leukemia (08876924), 2007, v. 21, n. 8, p. 1638, doi. 10.1038/sj.leu.2404732

By:

Mikesch, J.-H.;
Steffen, B.;
Berdel, W. E.;
Serve, H.;
Müller-Tidow, C.

Publication type:

Article

TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations.

Published in:

Leukemia (08876924), 2007, v. 21, n. 8, p. 1658, doi. 10.1038/sj.leu.2404750

By:

Pardanani, A.;
Hood, J.;
Lasho, T.;
Levine, R. L.;
Martin, M. B.;
Noronha, G.;
Finke, C.;
Mak, C. C.;
Mesa, R.;
Zhu, H.;
Soll, R.;
Gilliland, D. G.;
Tefferi, A.

Publication type:

Article

The Wilms’ tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis.

Published in:

Leukemia (08876924), 2007, v. 21, n. 8, p. 1783, doi. 10.1038/sj.leu.2404752

By:

Hosen, N.;
T.Shirakata;
Nishida, S.;
Yanagihara, M.;
Tsuboi, A.;
Kawakami, M.;
Oji, Y.;
Oka, Y.;
Okabe, M.;
Tan, B.;
Sugiyama, H.;
Weissman, I. L.

Publication type:

Article

Identification of two distinct MYC breakpoint clusters and their association with various IGH breakpoint regions in the t(8;14) translocations in sporadic Burkitt-lymphoma.

Published in:

Leukemia (08876924), 2007, v. 21, n. 8, p. 1739, doi. 10.1038/sj.leu.2404753

By:

Busch, K.;
Keller, T.;
Fuchs, U.;
Yeh, R.-F.;
Harbott, J.;
Klose, I.;
Wiemels, J.;
Novosel, A.;
Reiter, A.;
Borkhardt, A.

Publication type:

Article

Aberrant marker expression patterns on the CD34+CD38− stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission.

Published in:

Leukemia (08876924), 2007, v. 21, n. 8, p. 1700, doi. 10.1038/sj.leu.2404754

By:

van Rhenen, A.;
Moshaver, B.;
Kelder, A.;
Feller, N.;
Nieuwint, A. W. M.;
Zweegman, S.;
Ossenkoppele, G. J.;
Schuurhuis, G. J.

Publication type:

Article

The history of angiogenesis inhibitors.

Published in:

2007

By:

Ribatti, D.

Publication type:

Editorial

Clonality of the stem cell compartment during evolution of myelodysplastic syndromes and other bone marrow failure syndromes.

Published in:

Leukemia (08876924), 2007, v. 21, n. 8, p. 1648, doi. 10.1038/sj.leu.2404757

By:

Tiu, R.;
Gondek, L.;
O'Keefe, C.;
Maciejewski, J. P.

Publication type:

Article

Apoptosis induced by histone deacetylase inhibitors in leukemic cells is mediated by Bim and Noxa.

Published in:

2007

By:

Inoue, S.;
Riley, J.;
Gant, T. W.;
Dyer, M. J. S.;
Cohen, G. M.

Publication type:

journal article

The ρ-kinase inhibitors Y-27632 and fasudil act synergistically with imatinib to inhibit the expansion of ex vivo CD34+ CML progenitor cells.

Published in:

Leukemia (08876924), 2007, v. 21, n. 8, p. 1708, doi. 10.1038/sj.leu.2404762

By:

Burthem, J.;
Rees-Unwin, K.;
Mottram, R.;
Adams, J.;
Lucas, G. S.;
Spooncer, E.;
Whetton, A. D.

Publication type:

Article

Proinflammatory response of human leukemic cells to dsRNA transfection linked to activation of dendritic cells.

Published in:

Leukemia (08876924), 2007, v. 21, n. 8, p. 1691, doi. 10.1038/sj.leu.2404763

By:

Smits, E. L. J. M.;
Ponsaerts, P.;
Van de Velde, A. L. R.;
Van Driessche, A.;
Cools, N.;
Lenjou, M.;
Nijs, G.;
Van Bockstaele, D. R.;
Berneman, Z. N.;
Van Tendeloo, V. F. I.

Publication type:

Article

Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine.

Published in:

Leukemia (08876924), 2007, v. 21, n. 8, p. 1715, doi. 10.1038/sj.leu.2404764

By:

Van Den Neste, E.;
Robin, V.;
Francart, J.;
Hagemeijer, A.;
Stul, M.;
Vandenberghe, P.;
Delannoy, A.;
Sonet, A.;
Deneys, V.;
Costantini, S.;
Ferrant, A.;
Robert, A.;
Michaux, L.

Publication type:

Article

A sub-population of high proliferative potential-quiescent human mesenchymal stem cells is under the reversible control of interferon α/β.

Published in:

2007

By:

Peiffer1, I;
Eid2, P;
Barbet3, R;
Li4, M L;
Oostendorp5, R A J;
Haydont6, V;
Monier7, M-N;
Milon8, L;
Fortunel9, N;
Charbord10, P;
Tovey11, M;
Hatzfeld12, J;
Hatzfeld13, A

Publication type:

Correction Notice

The hunt for cancer-initiating cells: a history stemming from leukemia.

Published in:

Leukemia (08876924), 2007, v. 21, n. 8, p. 1619, doi. 10.1038/sj.leu.2404768

By:

Buzzeo, M. P.;
Scott, E. W.;
Cogle, C. R.

Publication type:

Article

Focal adhesion kinase is required for CXCL12-induced chemotactic and pro-adhesive responses in hematopoietic precursor cells.

Published in:

Leukemia (08876924), 2007, v. 21, n. 8, p. 1723, doi. 10.1038/sj.leu.2404769

By:

Glodek, A. M.;
Le, Y.;
Dykxhoorn, D. M.;
Park, S.-Y.;
Mostoslavsky, G.;
Mulligan, R.;
Lieberman, J.;
Beggs, H. E.;
Honczarenko, M.;
Silberstein, L. E.

Publication type:

Article

BH3 mimetic ABT-737 neutralizes resistance to FLT3 inhibitor treatment mediated by FLT3-independent expression of BCL2 in primary AML blasts.

Published in:

Leukemia (08876924), 2007, v. 21, n. 8, p. 1763, doi. 10.1038/sj.leu.2404776

By:

Kohl, T. M.;
Hellinger, C.;
Ahmed, F.;
Buske, C.;
Hiddemann, W.;
Bohlander, S. K.;
Spiekermann, K.

Publication type:

Article

Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells.

Published in:

Leukemia (08876924), 2007, v. 21, n. 8, p. 1733, doi. 10.1038/sj.leu.2404777

By:

Le Blanc, K.;
Samuelsson, H.;
Gustafsson, B.;
Remberger, M.;
Sundberg, B.;
Arvidson, J.;
Ljungman, P.;
Lönnies, H.;
Nava, S.;
Ringdén, O.

Publication type:

Article

MN1 overexpression is an important step in the development of inv(16) AML.

Published in:

Leukemia (08876924), 2007, v. 21, n. 8, p. 1679, doi. 10.1038/sj.leu.2404778

By:

Carella, C.;
Bonten, J.;
Sirma, S.;
Kranenburg, T. A.;
Terranova, S.;
Klein-Geltink, R.;
Shurtleff, S.;
Downing, J. R.;
Zwarthoff, E. C.;
Liu, P. P.;
Grosveld, G. C.

Publication type:

Article

Transcriptional regulation of parathyroid hormone-related protein promoter P2 by NF-kappaB in adult T-cell leukemia/lymphoma.

Published in:

2007

By:

Nadella, M. V. P.;
Dirksen, W. P.;
Nadella, K. S.;
Shu, S.;
Cheng, A. S.;
Morgenstern, J. A.;
Richard, V.;
Fernandez, S. A.;
Huang, T. H.;
Guttridge, D.;
Rosol, T. J.

Publication type:

journal article

Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)

Published in:

Leukemia (08876924), 2007, v. 21, n. 8, p. 1802, doi. 10.1038/sj.leu.2404781

By:

Tarella, C.;
Zanni, M.;
Di Nicola, M.;
Patti, C.;
Calvi, R.;
Pescarollo, A.;
Zoli, V.;
Fornari, A.;
Novero, D.;
Cabras, A.;
Stella, M.;
Comino, A.;
Remotti, D.;
Ponzoni, M.;
Caracciolo, D.;
Ladetto, M.;
Magni, M.;
Devizzi, L.;
Rosato, R.;
Boccadoro, M.

Publication type:

Article

Deguelin inhibits expression of IkappaBalpha protein and induces apoptosis of B-CLL cells in vitro.

Published in:

2007

By:

Geeraerts, B.;
Vanhoecke, B.;
Vanden Berghe, W.;
Philippé, J.;
Offner, F.;
Deforce, D.;
Philippé, J

Publication type:

journal article

PS-341 or a combination of arsenic trioxide and interferon-α inhibit growth and induce caspase-dependent apoptosis in KSHV/HHV-8-infected primary effusion lymphoma cells.

Published in:

Leukemia (08876924), 2007, v. 21, n. 8, p. 1792, doi. 10.1038/sj.leu.2404797

By:

Abou-Merhi, R.;
Khoriaty, R.;
Arnoult, D.;
El Hajj, H.;
Dbouk, H.;
Munier, S.;
El-Sabban, M. E.;
Hermine, O.;
Gessain, A.;
de Thé, H.;
Mahieux, R.;
Bazarbachi, A.

Publication type:

Article

Impairment of Na+,K+-ATPase in CD95(APO-1)-induced human T-cell leukemia cell apoptosis mediated by glutathione depletion and generation of hydrogen peroxide.

Published in:

Leukemia (08876924), 2007, v. 21, n. 8, p. 1669, doi. 10.1038/sj.leu.2404791

By:

Yin, W.;
Cheng, W.;
Shen, W.;
Shu, L.;
Zhao, J.;
Zhang, J.;
Hua, Z.-C.

Publication type:

Article

Imaging and angiogenesis in hematological malignancies.

Published in:

2007

By:

Longo, V.;
Vacca, A.;
Ribatti, D.

Publication type:

Editorial

MALT lymphoma in patients with autoimmune diseases: a comparative analysis of characteristics and clinical course.

Published in:

Leukemia (08876924), 2007, v. 21, n. 8, p. 1812, doi. 10.1038/sj.leu.2404782

By:

Wöhrer, S.;
Troch, M.;
Streubel, B.;
Zwerina, J.;
Skrabs, C.;
Formanek, M.;
Hauff, W.;
Hoffmann, M.;
Müllauer, L.;
Chott, A.;
Raderer, M.

Publication type:

Article